All In Biotech

Drug Trial Radar · NCT00216879

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel

Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

800

Actual

Start

Feb 2005

Primary completion

Not stated

Study completion Jul 2006

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to study the safety and efficacy of long term use of once daily applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to calcipotriol alone in the same gel. The primary response criteria will be the incidence of adverse drug reactions of any type, and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp.

Conditions

  • Psoriasis of Scalp

Interventions

  • Calcipotriol plus betamethasone dipropionate gel (LEO 80185)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportions of patients who experience adverse drug reactions and the proportion of patients who experience adverse events of concern associated with long-term topical corticosteroid use on the scalp during the study

Locations

5 sites in 5 countries. Site status is shown where the registry gives one.

  • Clinique de Dermatologie

    Moncton, Canada

  • Hørsholm Hospital, Dermatological Department

    Hørsholm, Denmark

  • Hôpital Nord, Service de Dermatologie

    Saint-Etienne, France

  • Universitätsklinikum Münster, Klinik und Poliklinik für Hautkrankheiten

    Münster, Germany

  • Monklands Hospital, Department of Dermatology

    Airdrie, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.